Drug
mogamulizumab-kpkc
Marketed as POTELIGEO.
Generic name
mogamulizumab-kpkc
Brand names
POTELIGEO
First FDA approval
2018-08-08
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761051 | POTELIGEO | 2018-08-08 | KYOWA KIRIN |
Manufacturers
KYOWA KIRIN
Frequently asked questions
When was mogamulizumab-kpkc FDA approved?
Earliest FDA approval on record: 2018-08-08.
What brand names are sold as mogamulizumab-kpkc?
POTELIGEO.
Sources
Appeal a mogamulizumab-kpkc denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com